JP2024506612A5 - - Google Patents
Info
- Publication number
- JP2024506612A5 JP2024506612A5 JP2023547775A JP2023547775A JP2024506612A5 JP 2024506612 A5 JP2024506612 A5 JP 2024506612A5 JP 2023547775 A JP2023547775 A JP 2023547775A JP 2023547775 A JP2023547775 A JP 2023547775A JP 2024506612 A5 JP2024506612 A5 JP 2024506612A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- aforementioned
- adenocarcinoma
- cell carcinoma
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (15)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2021076144 | 2021-02-09 | ||
| CNPCT/CN2021/076144 | 2021-02-09 | ||
| CNPCT/CN2021/091050 | 2021-04-29 | ||
| CN2021091050 | 2021-04-29 | ||
| CNPCT/CN2021/117189 | 2021-09-08 | ||
| CN2021117189 | 2021-09-08 | ||
| CN2021119368 | 2021-09-18 | ||
| CNPCT/CN2021/119368 | 2021-09-18 | ||
| CNPCT/CN2021/124714 | 2021-10-19 | ||
| CN2021124714 | 2021-10-19 | ||
| CN2021128807 | 2021-11-04 | ||
| CNPCT/CN2021/128807 | 2021-11-04 | ||
| CNPCT/CN2021/129056 | 2021-11-05 | ||
| CN2021129056 | 2021-11-05 | ||
| PCT/CN2022/073906 WO2022170974A1 (en) | 2021-02-09 | 2022-01-26 | Tricyclic derivatives useful as parp7 inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024506612A JP2024506612A (ja) | 2024-02-14 |
| JP2024506612A5 true JP2024506612A5 (cg-RX-API-DMAC7.html) | 2025-01-31 |
| JP7885229B2 JP7885229B2 (ja) | 2026-07-06 |
Family
ID=82838260
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023547775A Active JP7885229B2 (ja) | 2021-02-09 | 2022-01-26 | Parp7阻害剤として有用な三環式誘導体 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240336629A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4291560A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7885229B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230167755A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116848114A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022220924A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112023015721A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3210885A1 (cg-RX-API-DMAC7.html) |
| TW (1) | TW202246266A (cg-RX-API-DMAC7.html) |
| UY (1) | UY39625A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022170974A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240166664A1 (en) * | 2021-02-03 | 2024-05-23 | Shanghai Apeiron Therapeutics Company Limited | Triheterocyclic compound, preparation method therefor, and application thereof |
| WO2022223022A1 (zh) * | 2021-04-23 | 2022-10-27 | 四川海思科制药有限公司 | 一种并环杂环衍生物及其在医药上的应用 |
| WO2022247839A1 (zh) * | 2021-05-25 | 2022-12-01 | 山东轩竹医药科技有限公司 | Parp7抑制剂 |
| TW202416984A (zh) * | 2022-08-17 | 2024-05-01 | 大陸商北京加科思新藥研發有限公司 | 化合物i或其鹽的固體形式 |
| CN117551080A (zh) * | 2022-11-11 | 2024-02-13 | 杭州师范大学 | 一种靶向降解parp7的protac化合物及其制备方法与应用 |
| CN118388414A (zh) * | 2023-01-17 | 2024-07-26 | 中国药科大学 | 哒嗪酮类化合物及其制备方法、药物组合物和应用 |
| AU2024334795A1 (en) * | 2023-09-01 | 2026-04-02 | Chongqing Pharscin Innobio Co., Ltd. | Parp7 inhibitor and use thereof |
| US20250230168A1 (en) | 2023-12-22 | 2025-07-17 | Gilead Sciences, Inc. | Azaspiro wrn inhibitors |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103570725B (zh) * | 2012-08-01 | 2017-03-22 | 中国科学院上海药物研究所 | 哌嗪并三唑类化合物及其制备方法和用途 |
| CN103833756B (zh) * | 2012-11-26 | 2016-12-21 | 中国科学院上海药物研究所 | 一类哒嗪酮类化合物及其制备方法和用途 |
| US12435078B2 (en) | 2017-09-18 | 2025-10-07 | Gfb (Abc), Llc | Pyridazinones and methods of use thereof |
| BR112020022006A2 (pt) * | 2018-04-30 | 2021-01-26 | Ribon Therapeutics Inc. | piridazinonas como inibidores de parp7 |
| WO2020094084A1 (zh) * | 2018-11-07 | 2020-05-14 | 南京明德新药研发有限公司 | 作为ret抑制剂的三并环衍生物 |
| CN114096533B (zh) * | 2019-09-10 | 2024-03-08 | 四川科伦博泰生物医药股份有限公司 | 一种三并环类化合物,包含其的药物组合物,其制备方法及其用途 |
| WO2021087018A1 (en) * | 2019-10-30 | 2021-05-06 | Ribon Therapeutics, Inc. | Pyridazinones as parp7 inhibitors |
| TWI902715B (zh) | 2019-10-30 | 2025-11-01 | 美商律幫治療股份有限公司 | 作為parp7抑制劑的嗒酮 |
| US20240166664A1 (en) * | 2021-02-03 | 2024-05-23 | Shanghai Apeiron Therapeutics Company Limited | Triheterocyclic compound, preparation method therefor, and application thereof |
-
2022
- 2022-01-26 EP EP22752135.8A patent/EP4291560A4/en active Pending
- 2022-01-26 JP JP2023547775A patent/JP7885229B2/ja active Active
- 2022-01-26 WO PCT/CN2022/073906 patent/WO2022170974A1/en not_active Ceased
- 2022-01-26 CN CN202280014244.8A patent/CN116848114A/zh active Pending
- 2022-01-26 BR BR112023015721A patent/BR112023015721A2/pt not_active Application Discontinuation
- 2022-01-26 US US18/276,269 patent/US20240336629A1/en active Pending
- 2022-01-26 CA CA3210885A patent/CA3210885A1/en active Pending
- 2022-01-26 AU AU2022220924A patent/AU2022220924A1/en not_active Abandoned
- 2022-01-26 KR KR1020237030816A patent/KR20230167755A/ko active Pending
- 2022-01-26 TW TW111103378A patent/TW202246266A/zh unknown
- 2022-02-04 UY UY0001039625A patent/UY39625A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| He et al. | WNT/β-catenin signaling in the development of liver cancers | |
| Zheng et al. | Lysine demethylase 5B (KDM5B): a potential anti-cancer drug target | |
| Roviello et al. | Treatment of peritoneal carcinomatosis with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: state of the art and future developments | |
| JP2022548057A5 (cg-RX-API-DMAC7.html) | ||
| JP2011521618A5 (cg-RX-API-DMAC7.html) | ||
| Jiang | CAS (CSE1L) signaling pathway in tumor progression and its potential as a biomarker and target for targeted therapy | |
| JP2020508302A5 (cg-RX-API-DMAC7.html) | ||
| JP2023500483A5 (cg-RX-API-DMAC7.html) | ||
| Lau et al. | Ciliated muconodular papillary tumor: a solitary peripheral lung nodule in a teenage girl | |
| Espersen et al. | Clinical implications of intestinal stem cell markers in colorectal cancer | |
| JP2007153894A5 (cg-RX-API-DMAC7.html) | ||
| JP2022153392A5 (cg-RX-API-DMAC7.html) | ||
| JP2021520349A5 (cg-RX-API-DMAC7.html) | ||
| GEAP202416383A (en) | Use of medicament in treatment of tumor disease | |
| Chen et al. | Coptidis rhizoma and berberine as anti-cancer drugs: A 10-year updates and future perspectives | |
| RU2016128396A (ru) | Новые способы лечения рака | |
| Ke-Chun et al. | The role of SPDEF in cancer: promoter or suppressor. | |
| RU2015156221A (ru) | Фармацевтические комбинация ингибитора pi3k и средства, дестабилизирующего микротрубочки | |
| JP2024536719A5 (cg-RX-API-DMAC7.html) | ||
| JP2023515687A5 (cg-RX-API-DMAC7.html) | ||
| JP2025507923A5 (cg-RX-API-DMAC7.html) | ||
| JP2013537228A5 (cg-RX-API-DMAC7.html) | ||
| WO2006014903A3 (en) | Compositions and methods of use for adam12 antagonists in treating disease | |
| JPWO2023048231A5 (cg-RX-API-DMAC7.html) | ||
| EP3478293A1 (en) | Maintenance therapy for the treatment of cancer |